Article summary
Fifty-five years after its adoption, the 1971 United Nations Convention on Psychotropic Substances continues to function as the backbone of the international regime that restricts access to compounds such as DMT, psilocybin, and mescaline. Most national legislation, clinical research frameworks, and, by extension, the line that separates people who work with traditional medicines from those [β¦]
Continue to the original publication for the complete article.